Related references
Note: Only part of the references are listed.Antimicrobial resistance of Helicobacter pylori in West Flanders - Belgium: an observational cross-sectional study
Alexander Vanden Bulcke et al.
ACTA CLINICA BELGICA (2022)
Survey of the antimicrobial resistance ofHelicobacter pyloriin France in 2018 and evolution during the previous 5 years
Francis Megraud et al.
HELICOBACTER (2021)
Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection
J-C Delchier et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
Jyh-Ming Liou et al.
LANCET INFECTIOUS DISEASES (2019)
Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
Youn I. Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Molecular characterization of Helicobacter pylori resistance to rifamycins
Constantin Hays et al.
HELICOBACTER (2018)
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study
D. -S. Liu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
Alessia Savoldi et al.
GASTROENTEROLOGY (2018)
Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study
Bjorn Pasternak et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study
Bjorn Pasternak et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000-2016
Emily Mosites et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Real-time PCR for Helicobacter pylori diagnosis. The best tools available
Lucie Benejat et al.
HELICOBACTER (2018)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Detection of viable Helicobacter pylori inside free-living amoebae in wastewater and drinking water samples from Eastern Spain
Laura Moreno-Mesonero et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
Towards a healthy stomach? Helicobacter pylori prevalence has dramatically decreased over 23 years in adults in a Swedish community
Lars Agreus et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations
Muhammad Miftahussurur et al.
PLOS ONE (2016)
Identification of Viable Helicobacter pylori in Drinking Water Supplies by Cultural and Molecular Techniques
Paula Santiago et al.
HELICOBACTER (2015)
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study
Nick Daneman et al.
BMJ OPEN (2015)
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study
Jyh-Ming Liou et al.
PLOS ONE (2015)
The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America
M. Constanza Camargo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes
Akira Iwamoto et al.
GUT PATHOGENS (2014)
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
Francis Megraud et al.
GUT (2013)
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)
Niels Adriaenssens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009)
Niels Adriaenssens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori
Kenro Hirata et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance
Zhi-Qiang Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Well water -: one source of Helicobacter pylori colonization
UE Rolle-Kampczyk et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2004)
H pylori antibiotic resistance:: prevalence, importance, and advances in testing
F Mégraud
GUT (2004)
European Multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori
Y Glupczynski et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Share Paper
